News from boston scientific A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 06, 2013, 09:00 ET

Boston Scientific Reports Favorable Results Assessing Real-World Experience with the Precision Spectra™ Spinal Cord Stimulator System

 New retrospective data highlighting the Boston Scientific Corporation (NYSE: BSX) Precision Spectra™ Spinal Cord Stimulator (SCS) System...

Dec 06, 2013, 07:00 ET

Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement for Promus PREMIER™ Stent System

 Boston Scientific Corporation (NYSE: BSX) and The Medicines Company (NASDAQ: MDCO) announce a co-promotion agreement for the Boston Scientific...

Nov 26, 2013, 05:00 ET

Il sistema di stimolazione cerebrale profonda di Boston Scientific, Vercise™, riceve l'approvazione del marchio ce per il trattamento della distonia

Il primo sistema che stimola in maniera selettiva aree mirate del cervello per gestire i sintomi di questa patologia debilitante Il sistema di...

Nov 26, 2013, 02:00 ET

El sistema de estimulación cerebral profunda Vercise™ recibe el marcado CE para el tratamiento de la distonía

Primer sistema que estimula selectivamente áreas cerebrales concretas para tratar los síntomas debilitadores de esta enfermedad El...

Nov 26, 2013, 02:00 ET

Vercise™, systeme de stimulation cerebrale profonde de Boston Scientific, obtient le marquage CE dans le traitement de la dystonie

Premier système stimulant sélectivement des régions ciblées du cerveau afin de soulager les symptômes de la dystonie, une...

Nov 25, 2013, 09:00 ET

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug...

Nov 25, 2013, 02:00 ET

Das Vercise™-System zur tiefen Hirnstimulation von Boston Scientific hat die CE-Kennzeichnung zur Behandlung von Dystonie erhalten

Das erste System zur selektiven Stimulation ausgewählter Hirnbereiche zur Behandlung der Symptome dieser schwer beeinträchtigenden...

Nov 22, 2013, 09:06 ET

Boston Scientific To Participate In 25th Annual Piper Jaffray Healthcare Conference

 Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 25th Annual Piper Jaffray Healthcare Conference on December 3 in...

Nov 21, 2013, 17:01 ET

Susan Lisa Named Vice President Of Investor Relations Of Boston Scientific

Boston Scientific Corporation (NYSE: BSX) announces the appointment of Susan (Susie) Vissers Lisa as vice president, Investor Relations, effective...

Nov 19, 2013, 18:02 ET

Boston Scientific Receives FDA Clearance And CE Mark Approval For Direxion™ Torqueable Microcatheter

 Further bolstering its market-leading portfolio of peripheral embolization technologies, Boston Scientific Corporation (NYSE: BSX) has...

Nov 19, 2013, 04:00 ET

Boston Scientific Vercise™ Deep Brain Stimulation System Receives CE Mark Approval for Treatment of Dystonia

The Boston Scientific Corporation (NYSE: BSX) Vercise™ Deep Brain Stimulation (DBS) System has received CE Mark approval for the treatment...

Nov 15, 2013, 10:54 ET

Boston Scientific Announces First Commercial Implants Of The Lotus™ Valve System in Europe

 Marking a major step forward in the evolution of Transcatheter Aortic Valve Implantation (TAVI) technology, the first two commercial...

Nov 06, 2013, 06:41 ET

La valve Lotus™ de Boston Scientific atteint le critèreprincipal de performance de l'essai REPRISE II

Les nouvelles données présentées à la conférence TCT 2013 montrent un déploiement réussi pour l'ensemble des...

Nov 06, 2013, 06:14 ET

Lotus™ -Klappensystem von Boston Scientific erreicht den primären Endpunkt der REPRISE II Studie

Neue Daten, die auf dem TCT Kongress 2013 veröffentlicht wurden, zeigen den erfolgreichen Einsatz bei allen 120 Patienten ohne Auftreten...

Nov 06, 2013, 05:20 ET

Boston Scientific obtient le marquage ce pour la valve Lotus™

Positionnement et mise en place de précision pour ce dispositif de remplacement valvulaire aortique percutané (TAVR) qui offre à...

Nov 06, 2013, 05:17 ET

Lotus™ -Klappensystem von Boston Scientific erhält CE-Kennzeichnung

Das Gerät zum Transkatheter-Aortenklappenersatz (TAVR) ermöglicht eine präzise Positionierung und Platzierung, die Ärzten eine...

Nov 06, 2013, 05:11 ET

Les dernieres donnees confirment la reduction significative et durable de la pression arterielle grace au systeme de denervation renale Vessix™ de Boston Scientific

Les résultats de l'étude REDUCE-HTN présentés aujourd'hui au TCT démontrent l'excellent profil de sécurité...

Nov 06, 2013, 05:07 ET

Neue Daten zeigen weiterhin eine signifikante und nachhaltige blutdruckreduktion bei einsatz des Vessix™-Systems zur renalen Denervierung von Boston Scientific

Im Rahmen der TCT-Konferenz präsentierte Daten der REDUCE-HTN Studie belegen das exzellente Sicherheitsprofil Bei Patienten, die mit dem...

Nov 01, 2013, 10:15 ET

Boston Scientific Completes Acquisition Of Bard Electrophysiology

 Boston Scientific Corporation (NYSE:BSX) today closed on its previously announced agreement to acquire Bard EP, the electrophysiology (EP)...

Oct 31, 2013, 17:40 ET

Boston Scientific Lotus™ Valve System Meets Primary Performance Endpoint In REPRISE II Trial

 The Boston Scientific Corporation (NYSE: BSX) Lotus™ Valve System met a key performance measure in the treatment of symptomatic...